Glufosinate Market by Crop Type and Formulation Type - Global Industry Analysis & Forecast to 2027
Published On : July 2019 Pages : 140 Category: Renewable Chemicals Report Code : CM074366
Glufosinate Market by Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, and Others), and Formulation Type (Aqueous Suspension, Suspension Concentrate, Liquid, Soluble (Liquid) Concentrate, and Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Improvement of hereditarily changed glufosinate-tolerant yields is the essential factor driving glufosinate market development. Furthermore, its interest is foreseen to increment in the estimate time frame because of its capacity to target wide weed range and high viability. Nonetheless, glufosinate herbicides cause lethality in creatures and greenery and fauna, which may hamper the market development. Utilization of glufosinate is impressively protected on harvest plants when contrasted with different herbicides, and it tends to be utilized in blend with different herbicides, which makes it a worthwhile choice for the two makers and farmers. Glufosinate is a normally happening herbicide confined from two types of Streptomyces parasites.
Drivers and Restraints
Glufosinate is a normally happening herbicide secluded from two types of Streptomyces growths. It is broadly utilized as a substitute of glyphosate and paraquat to control wide scope of weeds, for example, morning wonders, hemp (Sesbania bispinosa), Pennsylvania smartweed (Polygonum Pensylvanicum), and others. Its use as a yield desiccator encourages reaping. Rising worries toward wide utilization of agrochemicals in different yields has prompted a move toward bio-based arrangements, which is required to help development of the glufosinate market.
Regional Insights
North America has the most extreme market potential for new contestants in the glufosinate advertise, attributable to rising interest for bio-based agricultural sector.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Bayer CropScience
- Hebei Veyong Bio-Chemical Co., Ltd.
- Hebei Bestar Bio-Technology Co., Ltd.
- Inner Mongolia Jiaruimi Fine Chemical Co., Ltd.
- Jiangsu Huangma Agrochemicals Co., Ltd.
- Jiangsu Sevencontinent Green Chemical Co., Ltd.
- Lier Chemical Company Ltd.
- Zhejiang Yongnong Chem. Ind. Co., Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Glufosinate Market, By Crop Type, Estimates and Forecast, 2017-2027 ($Million)
o Cereals & Grains,
o Fruits & Vegetables,
o Oilseeds & Pulses
o Others
· Glufosinate Market, By Formulation Type, Estimates and Forecast, 2017-2027 ($Million)
o Aqueous Suspension
o Suspension Concentrate
o Liquid
o Soluble (Liquid) Concentrate
o Others
· Glufosinate Market, By Key Players
o Bayer CropScience
o Hebei Veyong Bio-Chemical Co., Ltd.
o Hebei Bestar Bio-Technology Co., Ltd.
o Inner Mongolia Jiaruimi Fine Chemical Co., Ltd.
o Jiangsu Huangma Agrochemicals Co., Ltd.
o Jiangsu Sevencontinent Green Chemical Co., Ltd.
o Lier Chemical Company Ltd.
o Zhejiang Yongnong Chem. Ind. Co., Ltd.
· Glufosinate Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Glufosinate Market, By Country
o U.S. Glufosinate Market
o Canada Glufosinate Market
o Mexico Glufosinate Market
o Europe
§ Europe Glufosinate Market, By Country
o Germany Glufosinate Market
o UK Glufosinate Market
o France Glufosinate Market
o Russia Glufosinate Market
o Italy Glufosinate Market
o Rest of Europe Glufosinate Market
o Asia-Pacific
§ Asia-Pacific Glufosinate Market, By Country
o China Glufosinate Market
o Japan Glufosinate Market
o South Korea Glufosinate Market
o India Glufosinate Market
o Southeast Asia Glufosinate Market
o Rest of Asia-Pacific Glufosinate Market
o South America
§ South America Glufosinate Market
o Brazil Glufosinate Market
o Argentina Glufosinate Market
o Columbia Glufosinate Market
o Rest of South America Glufosinate Market
o Middle East and Africa
§ Middle East and Africa Glufosinate Market
o Saudi Arabia Glufosinate Market
o UAE Glufosinate Market
o Egypt Glufosinate Market
o Nigeria Glufosinate Market
o South Africa Glufosinate Market
o Rest of MEA Glufosinate Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Glufosinate Market, By Crop Type
5.1. Introduction
5.2. Global Glufosinate Revenue and Market Share by Crop Type (2017-2027)
5.2.1. Global Glufosinate Revenue and Revenue Share by Crop Type (2017-2027)
5.3. Cereals & Grains
5.3.1. Global Cereals & Grains Revenue and Growth Rate (2017-2027)
5.4. Fruits & Vegetables
5.4.1. Global Fruits & Vegetables Revenue and Growth Rate (2017-2027)
5.5. Oilseeds & Pulses
5.5.1. Global Oilseeds & Pulses Revenue and Growth Rate (2017-2027)
5.6. Others
5.6.1. Global Others Revenue and Growth Rate (2017-2027)
6. Glufosinate Market, By Formulation Type
6.1. Introduction
6.2. Global Glufosinate Revenue and Market Share by Formulation Type (2017-2027)
6.2.1. Global Glufosinate Revenue and Revenue Share by Formulation Type (2017-2027)
6.3. Aqueous Suspension
6.3.1. Global Aqueous Suspension Revenue and Growth Rate (2017-2027)
6.4. Suspension Concentrate
6.4.1. Global Suspension Concentrate Revenue and Growth Rate (2017-2027)
6.5. Liquid
6.5.1. Global Liquid Revenue and Growth Rate (2017-2027)
6.6. Soluble (Liquid) Concentrate
6.6.1. Global Soluble (Liquid) Concentrate Revenue and Growth Rate (2017-2027)
6.7. Others
6.7.1. Global Others Revenue and Growth Rate (2017-2027)
7. Glufosinate Market, By Region
7.1. Introduction
7.2. Global Glufosinate Revenue and Market Share by Regions
7.2.1. Global Glufosinate Revenue by Regions (2017-2027)
7.3. North America Glufosinate by Countries
7.3.1. North America Glufosinate Revenue and Growth Rate (2017-2027)
7.3.2. North America Glufosinate Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Glufosinate by Countries
7.4.1. Europe Glufosinate Revenue and Growth Rate (2017-2027)
7.4.2. Europe Glufosinate Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Glufosinate by Countries
7.5.1. Asia-Pacific Glufosinate Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Glufosinate Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Glufosinate by Countries
7.6.1. South America Glufosinate Revenue and Growth Rate (2017-2027)
7.6.2. South America Glufosinate Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Glufosinate by Countries
7.7.1. Middle East and Africa Glufosinate Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Glufosinate Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Bayer CropScience
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Hebei Veyong Bio-Chemical Co., Ltd.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Hebei Bestar Bio-Technology Co., Ltd
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Inner Mongolia Jiaruimi Fine Chemical Co., Ltd.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Jiangsu Huangma Agrochemicals Co., Ltd
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Jiangsu Sevencontinent Green Chemical Co., Ltd.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Lier Chemical Company Ltd.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Zhejiang Yongnong Chem. Ind. Co., Ltd
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Glufosinate Market Forecast (2017-2027)
9.1. Global Glufosinate Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Glufosinate Market Forecast by Regions (2017-2027)
9.2.1. North America Glufosinate Market Forecast (2017-2027)
9.2.1.1. United States Glufosinate Market Forecast (2017-2027)
9.2.1.2. Canada Glufosinate Market Forecast (2017-2027)
9.2.1.3. Mexico Glufosinate Market Forecast (2017-2027)
9.2.2. Europe Glufosinate Market Forecast (2017-2027)
9.2.2.1. Germany Glufosinate Market Forecast (2017-2027)
9.2.2.2. France Glufosinate Market Forecast (2017-2027)
9.2.2.3. UK Glufosinate Market Forecast (2017-2027)
9.2.2.4. Russia Glufosinate Market Forecast (2017-2027)
9.2.2.5. Italy Glufosinate Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Glufosinate Market Forecast (2017-2027)
9.2.3. Asia-Pacific Glufosinate Market Forecast (2017-2027)
9.2.3.1. China Glufosinate Market Forecast (2017-2027)
9.2.3.2. Japan Glufosinate Market Forecast (2017-2027)
9.2.3.3. Korea Glufosinate Market Forecast (2017-2027)
9.2.3.4. India Glufosinate Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Glufosinate Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Glufosinate Market Forecast (2017-2027)
9.2.4. South America Glufosinate Market Forecast (2017-2027)
9.2.4.1. Brazil Glufosinate Market Forecast (2017-2027)
9.2.4.2. Argentina Glufosinate Market Forecast (2017-2027)
9.2.4.3. Columbia Glufosinate Market Forecast (2017-2027)
9.2.4.4. Rest of South America Glufosinate Market Forecast (2017-2027)
9.2.5. Middle East and Africa Glufosinate Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Glufosinate Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Glufosinate Market Forecast (2017-2027)
9.2.5.3. Egypt Glufosinate Market Forecast (2017-2027)
9.2.5.4. Nigeria Glufosinate Market Forecast (2017-2027)
9.2.5.5. South Africa Glufosinate Market Forecast (2017-2027)
9.2.5.6. Turkey Glufosinate Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Glufosinate Market Forecast (2017-2027)
9.3. Glufosinate Market Forecast by Crop Type (2017-2027)
9.3.1. Glufosinate Forecast by Crop Type (2017-2027)
9.3.2. Glufosinate Market Share Forecast by Crop Type (2017-2027)
9.4. Glufosinate Market Forecast by Formulation Type (2017-2027)
9.4.1. Glufosinate Forecast by Formulation Type (2017-2027)
9.4.2. Glufosinate Market Share Forecast by Formulation Type (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Glufosinate Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Glufosinate Revenue and Revenue Share by Crop Type (2017-2018)
Figure Global Cereals & Grains Revenue and Growth Rate (2017-2018)
Figure Global Fruits & Vegetables Revenue and Growth Rate (2017-2018)
Figure Global Oilseeds & Pulses Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Glufosinate Revenue and Revenue Share by Formulation Type (2017-2018)
Figure Global Aqueous Suspension Revenue and Growth Rate (2017-2018)
Figure Global Suspension Concentrate Revenue and Growth Rate (2017-2018)
Figure Global Liquid Revenue and Growth Rate (2017-2018)
Figure Global Soluble (Liquid) Concentrate Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Glufosinate Revenue by Regions (2017-2018)
Figure North America Glufosinate Growth Rate (2017-2018)
Figure North America Glufosinate Revenue and Growth Rate (2017-2018)
Figure North America Glufosinate by Countries (2017-2018)
Figure North America Glufosinate Revenue (Million USD) by Countries (2017-2018)
Figure United States Glufosinate Growth Rate (2017-2018)
Figure United States Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Glufosinate Growth Rate (2017-2018)
Figure Canada Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Glufosinate Growth Rate (2017-2018)
Figure Mexico Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Glufosinate Growth Rate (2017-2018)
Figure Europe Glufosinate Revenue and Growth Rate (2017-2018)
Figure Europe Glufosinate by Countries (2017-2018)
Figure Europe Glufosinate Revenue (Million USD) by Countries (2017-2018)
Figure Germany Glufosinate Growth Rate (2017-2018)
Figure Germany Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Glufosinate Growth Rate (2017-2018)
Figure France Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Glufosinate Growth Rate (2017-2018)
Figure UK Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Glufosinate Growth Rate (2017-2018)
Figure Russia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Glufosinate Growth Rate (2017-2018)
Figure Italy Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Glufosinate Growth Rate (2017-2018)
Figure Rest of Europe Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Glufosinate Growth Rate (2017-2018)
Figure Asia-Pacific Glufosinate Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Glufosinate by Countries (2017-2018)
Figure Asia-Pacific Glufosinate Revenue (Million USD) by Countries (2017-2018)
Figure China Glufosinate Growth Rate (2017-2018)
Figure China Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Glufosinate Growth Rate (2017-2018)
Figure Japan Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Glufosinate Growth Rate (2017-2018)
Figure Korea Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Glufosinate Growth Rate (2017-2018)
Figure India Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Glufosinate Growth Rate (2017-2018)
Figure Southeast Asia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Glufosinate Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Glufosinate Growth Rate (2017-2018)
Figure South America Glufosinate Revenue and Growth Rate (2017-2018)
Figure South America Glufosinate by Countries (2017-2018)
Figure South America Glufosinate Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Glufosinate Growth Rate (2017-2018)
Figure Brazil Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Glufosinate Growth Rate (2017-2018)
Figure Argentina Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Glufosinate Growth Rate (2017-2018)
Figure Columbia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Glufosinate Growth Rate (2017-2018)
Figure Rest of South America Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Glufosinate Growth Rate (2017-2018)
Figure Middle East and Africa Glufosinate Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Glufosinate by Countries (2017-2018)
Figure Middle East and Africa Glufosinate Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Glufosinate Growth Rate (2017-2018)
Figure Saudi Arabia Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Glufosinate Growth Rate (2017-2018)
Figure United Arab Emirates Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Glufosinate Growth Rate (2017-2018)
Figure Egypt Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Glufosinate Growth Rate (2017-2018)
Figure Nigeria Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Glufosinate Growth Rate (2017-2018)
Figure South Africa Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Glufosinate Growth Rate (2017-2018)
Figure Turkey Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Glufosinate Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Glufosinate Revenue (Millions USD) and Growth Rate (2017-2018)
Table Bayer CropScience Glufosinate Financial Overview
Table Hebei Veyong Bio-Chemical Co., Ltd. Glufosinate Financial Overview
Table Hebei Bestar Bio-Technology Co., Ltd Glufosinate Financial Overview
Table Inner Mongolia Jiaruimi Fine Chemical Co., Ltd. Glufosinate Financial Overview
Table Jiangsu Huangma Agrochemicals Co., Ltd Glufosinate Financial Overview
Table Jiangsu Sevencontinent Green Chemical Co., Ltd. Glufosinate Financial Overview
Table Lier Chemical Company Ltd. Glufosinate Financial Overview
Table Zhejiang Yongnong Chem. Ind. Co., Ltd Glufosinate Financial Overview
Figure Global Glufosinate Revenue (Millions USD) and Growth Rate (2018-2025)
Table Glufosinate Market Forecast by Regions (2018-2025)
Figure North America Glufosinate Market Forecast (2018-2025)
Figure United States Glufosinate Market Forecast (2018-2025)
Figure Canada Glufosinate Market Forecast (2018-2025)
Figure Mexico Glufosinate Market Forecast (2018-2025)
Figure Europe Glufosinate Market Forecast (2018-2025)
Figure Germany Glufosinate Market Forecast (2018-2025)
Figure France Glufosinate Market Forecast (2018-2025)
Figure UK Glufosinate Market Forecast (2018-2025)
Figure Russia Glufosinate Market Forecast (2018-2025)
Figure Italy Glufosinate Market Forecast (2018-2025)
Figure Rest of Europe Glufosinate Market Forecast (2018-2025)
Figure Asia-Pacific Glufosinate Market Forecast (2018-2025)
Figure China Glufosinate Market Forecast (2018-2025)
Figure Japan Glufosinate Market Forecast (2018-2025)
Figure Korea Glufosinate Market Forecast (2018-2025)
Figure India Glufosinate Market Forecast (2018-2025)
Figure Southeast Asia Glufosinate Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Glufosinate Market Forecast (2018-2025)
Figure South America Glufosinate Market Forecast (2018-2025)
Figure Brazil Glufosinate Market Forecast (2018-2025)
Figure Argentina Glufosinate Market Forecast (2018-2025)
Figure Columbia Glufosinate Market Forecast (2018-2025)
Figure Rest of South America Glufosinate Market Forecast (2018-2025)
Figure Middle East and Africa Glufosinate Market Forecast (2018-2025)
Figure Saudi Arabia Glufosinate Market Forecast (2018-2025)
Figure United Arab Emirates Glufosinate Market Forecast (2018-2025)
Figure Egypt Glufosinate Market Forecast (2018-2025)
Figure Nigeria Glufosinate Market Forecast (2018-2025)
Figure South Africa Glufosinate Market Forecast (2018-2025)
Figure Turkey Glufosinate Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Glufosinate Market Forecast (2018-2025)
Figure Global Glufosinate Forecast by Crop Type (2018-2025)
Figure Global Glufosinate Market Share Forecast by Crop Type (2018-2025)
Figure Global Glufosinate Forecast by Crop Type (2018-2025)
Figure Global Glufosinate Forecast by Formulation Type (2018-2025)
Figure Global Glufosinate Market Share Forecast by Formulation Type (2018-2025)
Figure Global Glufosinate Forecast by Formulation Type (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|